Cargando…
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study
(1) Introduction: Since May 2021, sotrovimab has been available in Italy for early treatment of SARS-CoV-2 infection and to prevent disease progression. However, some in vitro studies have questioned its efficacy on Omicron variants. Therefore, we aim to further investigate the efficacy of sotrovima...
Autores principales: | De Vito, Andrea, Colpani, Agnese, Poliseno, Mariacristina, Diella, Lucia, Ieva, Francesco Rosario Paolo, Belati, Alessandra, Papale, Roberto, Babudieri, Sergio, De Santis, Laura, Saracino, Annalisa, Lo Caputo, Sergio, Madeddu, Giordano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458484/ https://www.ncbi.nlm.nih.gov/pubmed/37632099 http://dx.doi.org/10.3390/v15081757 |
Ejemplares similares
-
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free
por: Fiore, Vito, et al.
Publicado: (2022) -
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience
por: Donisi, Alessandra, et al.
Publicado: (2023) -
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations
por: Fiore, Vito, et al.
Publicado: (2023) -
Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
por: De Vito, Andrea, et al.
Publicado: (2023) -
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era?
por: De Vito, Andrea, et al.
Publicado: (2023)